ABEONA THERAPEUTICS INC. Due to Related Parties, Noncurrent
ABEONA THERAPEUTICS INC. (ABEO) had Due to Related Parties, Noncurrent of $4.16 million as of 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Notes
us-gaap:DueToRelatedPartiesNoncurrent · last filed 2023-03-29
- 2022-12-31: Due to Related Parties, Noncurrent $4.16M.
- 2022-09-30: Due to Related Parties, Noncurrent $4.06M.
- 2022-06-30: Due to Related Parties, Noncurrent $4.01M.
- 2022-03-31: Due to Related Parties, Noncurrent $3.92M.
| Period end | Due to Related Parties, Noncurrent |
|---|---|
| 2022-12-31 | $4.16M 10-K · filed 2023-03-29 |
| 2022-09-30 | $4.06M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $4.01M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.92M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $3.83M 10-K · filed 2023-03-29 |
| 2021-09-30 | $8.36M 10-Q · filed 2021-11-15 |
| 2019-09-30 | $20.00M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $20.00M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |